These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 872919)
1. Fibrinogen turnover during the administration of high phospholipidic content placental extracts. Casale G; Ricotti MP; Caliandro LP Farmaco Prat; 1977 Jun; 32(6):312-7. PubMed ID: 872919 [No Abstract] [Full Text] [Related]
2. Immediate effect of components from the interior of human cells on blood coagulation. Clarke N; Collins M Ir J Med Sci; 1971 Feb; 140(2):60-70. PubMed ID: 5575703 [No Abstract] [Full Text] [Related]
3. Inhibition of coagulation by fibrinopeptides released during fibrinolysis. Schneider CL; Engstrom RM Bibl Anat; 1969; 10():469-73. PubMed ID: 5407402 [No Abstract] [Full Text] [Related]
4. [The effect of protamine sulfate on blood coagulation in intravenous administration of placental extract]. Skipetrov VP Patol Fiziol Eksp Ter; 1966; 10(4):69-70. PubMed ID: 5237748 [No Abstract] [Full Text] [Related]
5. [The effect of placentin-3--a new preparation from human placental tissue--on the blood coagulating system]. Limvinov VV Biull Eksp Biol Med; 1969 Feb; 67(2):19-21. PubMed ID: 5821421 [No Abstract] [Full Text] [Related]
6. Lipids and phospholipids in blood coagulation. Bermingham MA; Boggust WA; O'Meara RA Nature; 1968 May; 218(5142):695-6. PubMed ID: 5655964 [No Abstract] [Full Text] [Related]
7. [Inhibition of the thromboplastic effect of placental extracts using trasylol]. Slunsky R Z Geburtshilfe Perinatol; 1972 Jun; 176(3):201-6. PubMed ID: 4538438 [No Abstract] [Full Text] [Related]
12. Treatment of the experimental hemorrhagic radiation syndrome by means of placental extracts with high phospholipidic content. Coppi M; Spreafico PL; Casale G Farmaco Prat; 1976 Mar; 31(3):133-9. PubMed ID: 1253957 [No Abstract] [Full Text] [Related]
13. [Biological half-life of 131 I-labeled fibrinogen from normal and cobalt-treated rabbits]. Krantz S; Lober M; Oppermann P Acta Biol Med Ger; 1972; 29(6):805-10. PubMed ID: 4659761 [No Abstract] [Full Text] [Related]
14. Fibrinogen turnover and drugs acting on fibrinolysis. De Nicola P Acta Univ Carol Med Monogr; 1972; 52():25-31. PubMed ID: 4544612 [No Abstract] [Full Text] [Related]
15. [Chemical composition of lipoid anticoagulant and mechanism of its action]. Byshevsky AS; Mukhacheva IA Vopr Med Khim; 1975; 21(4):367-70. PubMed ID: 1216756 [TBL] [Abstract][Full Text] [Related]
16. Effect of intravenous administration of T-2 toxin on blood coagulation in calves. Gentry PA; Cooper ML Am J Vet Res; 1983 May; 44(5):741-6. PubMed ID: 6869975 [TBL] [Abstract][Full Text] [Related]
17. Degradation of fibrinogen by plasmin: biological effects of the non-dialysable fibrinogen derivatives. Triantaphyllopoulos DC; Chandra S Thromb Diath Haemorrh Suppl; 1973; 56():113-26. PubMed ID: 4281938 [No Abstract] [Full Text] [Related]
18. The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas. Pineo GF; Regoeczi E; Hatton MW; Brain MC J Lab Clin Med; 1973 Aug; 82(2):255-66. PubMed ID: 4352814 [No Abstract] [Full Text] [Related]
19. [Coagulation-active phospholipids. Contribution to the coagulation-physiological and chemical characterization of thrombocyte and placental extracts rich on phosphatides]. Trobisch H; Schwinn H Med Welt; 1974 Oct; 25(40):1604-8. PubMed ID: 4444498 [No Abstract] [Full Text] [Related]
20. Fibrinogen has a rapid turnover in the healthy newborn lamb. Andrew M; Mitchell L; Berry LR; Schmidt B; Hatton MW Pediatr Res; 1988 Mar; 23(3):249-52. PubMed ID: 3353168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]